OAK FINAL LOGO 2-1.jpg

  • Home

  • About Us

    • Our Mission
    • Our Team
    • Advisory Board

  • What We Do

    • Products
    • Research & Projects
    • Technology

  • Resources

    • Media
    • Presentations
    • White Papers

  • News

  • Contact Us

  • More

    Use tab to navigate through the menu items.
    • Wix Twitter page

    Oak Therapeutics receives NIH/NIAID contract

    We are proud to announce that we have received a contract from NIAID, the National Institute of Allergy and Infectious Diseases, a...
    Featured Posts

    OAK THERAPEUTICS SUCCESSFULLY CONCLUDES TRIAL OF MALARIA MEDICATION

    Recent Posts

    Oak Therapeutics and KU Medical Center cooperate on NIH-funded research

    Oak Therapeutics cooperates with KU Medical Center on HIV solutions

    Oak Therapeutics receives NIH/NIAID contract

    Oak Therapeutics in line for SBIR award

    Oak Therapeutics receives Central Coast Innovation Award!

    Listen to our co-founder Ed Maliski

    The beginning of a vaccine - the end of malaria?

    Oak Therapeutics Flip Book online

    The Pacific Coast Business Times reports on us!

    The Pacific Coast Business Times reports on us!

    It's all about the children - video

    Archive
    • March 2021 (1) 1 post
    • June 2019 (1) 1 post
    • October 2016 (1) 1 post
    • August 2016 (1) 1 post
    • February 2016 (1) 1 post
    • January 2016 (1) 1 post
    • July 2015 (4) 4 posts
    • June 2015 (2) 2 posts
    Search By Tags
    No tags yet.
    Follow Us
    • Facebook Basic Square
    • Twitter Basic Square
    • Google+ Basic Square

     31416 Agoura Rd. Ste. 105, Westlake Village, CA 91361 and 2029 Becker Drive, Lawrence, KS 66047, United States. Tel. +1-913-346-0990, Email: office@oaktherapeutics.com